Sale!
Retatrutide injection vial, supporting weight loss, blood sugar regulation, and metabolic health
Retatrutide 10mg

Retatrutide 10mg

Original price was: $199.99.Current price is: $169.99.

Structured research compound supply with batch verification and COA documentation available.
Fulfilled from the United States with secure packaging, tracking, and controlled handling standards.
✔ Batch verification
Analytical verification standards applied to support consistency.
✔ Secure checkout
Encrypted payment processing and structured order handling.
✔ Premium US shipping
UPS 2-Day Air with insulated packaging and cold-pack stabilization.
✔ Controlled fulfillment
Structured packaging and operational standards designed for consistency.
This compound is intended exclusively for research purposes and is not approved for human consumption.
It must be handled by qualified professionals in controlled laboratory settings.

Research Supply Standards Seal

Research Supply Standards
Quality, fulfillment, and documentation indicators displayed to support buyer confidence.
Buying Guide
Learn what serious buyers look for when comparing Retatrutide suppliers.
Categories: , ,
CRV Verified
CRV Verified Vendor
Click to view certification
Verification Code: CRV-RE-000001
Open Official CRV Record →

← Back to Research Peptides Catalog

Description

Retatrutide 10mg — Verified Research Peptide

Retatrutide 10mg is a batch-verified research peptide supplied for laboratory investigation, analytical applications, receptor signaling studies, and controlled research environments requiring consistency, traceability, and documentation.

Reviewed by:
Regentide Research Team

Last Updated: June 2026

Batch Verified
COA Available
USA Fulfillment
Research Use Only

Retatrutide 10mg Research Compound Overview

Retatrutide is a synthetic investigational peptide studied within modern peptide science for its interaction with multiple receptor systems. The compound has generated significant interest among researchers investigating receptor signaling, metabolic pathway activity, and multi-receptor agonist models.

Retatrutide 10mg provides researchers with a lower-concentration format that may be suitable for exploratory laboratory investigations, analytical testing workflows, and comparative research applications requiring smaller quantities.

Scientific Review

Educational information presented on this page has been reviewed by the
Regentide Research Team
for scientific accuracy, literature review standards, and Research Use Only compliance.

What Is Retatrutide?

Retatrutide (LY3437943) is an investigational peptide studied for interaction with three receptor pathways: GLP-1, GIP, and glucagon receptors. This triple-receptor profile distinguishes Retatrutide from many earlier peptide research compounds that focus on a single receptor pathway or dual receptor model.

Researchers continue to investigate how coordinated receptor activity may influence signaling mechanisms, peptide interactions, and downstream biological pathways under controlled research conditions.

Research Applications

Retatrutide is commonly discussed in scientific literature involving:

  • GLP-1 receptor signaling research
  • GIP pathway investigations
  • Glucagon receptor studies
  • Metabolic signaling models
  • Peptide engineering research
  • Comparative receptor agonist analysis
  • Laboratory analytical investigations
  • Cellular communication pathway studies

Its multi-receptor profile has contributed to growing interest within peptide science and receptor signaling research.

Why Researchers Choose the 10mg Format

The Retatrutide 10mg format is frequently considered by laboratories seeking a smaller concentration option for preliminary investigations, pilot research projects, analytical testing, or comparative evaluations.

  • Suitable for smaller-scale laboratory investigations
  • Useful for analytical verification procedures
  • Supports controlled pilot research workflows
  • Allows flexible comparison with other peptide concentrations
  • Facilitates laboratory screening studies

Quality & Verification Standards

Reliable peptide research depends on analytical consistency, traceability, and verification. Regentide maintains quality-focused handling procedures designed to support controlled research environments.

  • Research-grade handling procedures
  • Batch verification standards
  • Certificate of Analysis documentation available
  • Secure packaging procedures
  • Controlled fulfillment workflow
  • Verification-focused quality controls

Technical Specifications

Compound Retatrutide
Quantity 10mg
Format Lyophilized Powder
Storage Controlled laboratory conditions recommended
Use Laboratory research only

Published Scientific Literature

Retatrutide has been referenced in scientific literature involving receptor signaling pathways, peptide-receptor interactions, and metabolic pathway investigations.

  1. Coskun T, Sloop KW, Loghin C, et al.
    LY3437943, a Novel Triple GIP, GLP-1, and Glucagon Receptor Agonist.
    Cell Metabolism.
  2. Jastreboff AM, Kaplan LM, Frías JP, et al.
    Triple–Hormone-Receptor Agonist Retatrutide.
    New England Journal of Medicine.
  3. Urva S, et al.
    Clinical Investigation of LY3437943.
    The Lancet.

Shipping & Fulfillment

Orders are processed through Regentide’s fulfillment workflow and shipped securely from our USA-based facility. Tracking information is provided after dispatch to support transparency throughout delivery.

Controlled handling and fulfillment procedures help maintain consistency and product integrity throughout shipment.

Compare Available Retatrutide Concentrations

Researchers comparing concentration options may review additional Retatrutide formats depending on protocol requirements and research objectives.

Frequently Asked Questions

What is Retatrutide 10mg?

Retatrutide 10mg is a lyophilized research peptide supplied for laboratory and analytical applications.

What is another name for Retatrutide?

Retatrutide is also known by the research identifier LY3437943.

What receptors does Retatrutide target?

Retatrutide is studied for interaction with GLP-1, GIP, and glucagon receptor pathways.

Why choose Retatrutide 10mg?

The 10mg format may be useful for exploratory investigations, analytical testing, pilot studies, and smaller-scale laboratory research workflows.

Is Retatrutide intended for human use?

No. Retatrutide offered by Regentide is intended exclusively for laboratory research and analytical purposes.

Explore full compound insights:


Retatrutide Research Overview →


View Verification →

Research Use Notice

This compound is provided strictly for laboratory research purposes. It is not approved for human use, veterinary use, therapeutic applications, diagnostic procedures, or clinical use.

Disclaimer

Statements regarding this product have not been evaluated by regulatory authorities.

By purchasing, the customer acknowledges that they are qualified to handle research materials and assumes responsibility for proper laboratory use.

FDA Disclaimer:
The statements made regarding these products have not been evaluated by the U.S. Food and Drug Administration (FDA). These products are not intended to diagnose, treat, cure, or prevent any disease.

All products sold by Regentide are for laboratory and research use only (RUO). They are not for human consumption, medical, or veterinary use.

By purchasing, the customer acknowledges they are qualified to handle and use these materials, and that Regentide shall not be held liable for any misuse.

Related products